Miastenia gravis e síndromes miasténicos
Palavras-chave:
placa neuromuscular, miastenia gravis, síndroma miasténica de Eaton-Lambert, botulismoResumo
Os autores abordam a anatomia e neuroquímica da placa neuromuscular, a classificação das diferentes entidades, bem como as patologias mais frequentemente encontradas na clínica de adultos. São revistos a fisiopatologia, quadro clínico, diagnóstico diferencial e abordagem terapêutica da miastenia gravis, considerada o paradigma das doenças de envolvimento da placa neuromuscular, da síndroma miasténica de Eaton-Lambert e do botulismo.
Downloads
Referências
Engcl GA. The Neuromuscular Junction in Engel GA, Franzini Armstrong C (eds) Myology, McGraw-Hill, New York 1994; J · 261-287.
Kuppler SW, Yoshikami D. The number of transmitter molecules in the quantun: An estimate from iontophoretic apphcation of acetylcholine at the neuromuscular juntion. J Phisiol I 975; 251: 465-482.
Mieledi R, MolenaarPC, Polar RL. Electrophisiological and chemical determination of acetylcholine release at the frog neuromuscular juntion. J Phisiol 1983; 334: 245-254.
Myasthenia Gravis and Episodic forms of Muscular Weakness m Adams RD; Victor M (eds), Principies of Neurology, 5th ed1t1on, McGraw-Hill, New York 1993:1252-1270.
Oosterhuis HJ. Myasthenia gravis and other myasthenic syndromes in Swash M; Oxbury (eds), Clinical Neurology, Churchill Livingstone, New York 1991;2: 1368-1394.
Hopkins L. Autoimmune Myasthenia and Myasthenic Syndrome in AAN Annual Courses and Workshops, San Francisco, 1996.
Drachman D. Myasthenia Gravis in lsselbacher, Braunwald, Wilson, Martin, Fauci, Kasper (eds), Harrison's Principies of Internai Medicine, 13th edition, McGraw-Hill 1994; 2393-2396.
Oostherhuis H, Kuks J. Myasthenia Gravis and Myasthenic Syndromes. Curr Opin Neurol Neurosurg 1992; 5: 638-644.
Eymard B, Berrih-Aknin S. Rôle du Timus dans la Physiopathologie de la Myasthenie. Rev Neuro! 1995; 151: 6-15.
Steck A. Antibodies in the Neurology Clinic. Neurology 1990; 40: 1489-1492.
Kuks J, Limburg P, Horst G, et al. Antibodies to Skeletal Muscle in Myasthenia Gravis. Part 1. Diagnostic Value for the Detection of Timoma. J Neurol Sei 1993; 119: 183-188.
Kuks J, Limburg P, Horst G, Oostherhuis H. Antibodies to Skeletal Muscle in Myasthenia Gravis. Part 2. Prevalence in non Thymoma Patients. J Neurol Sei 1993; 120: 78-81.
Kuks J, Limburg P, Horst G, Oostherhuis H. Antibodies to Skeletal Muscle in Myasthenia Gravis. Part.3. Relation With Clinicai Course and Therapy J Neuro! Sei 1993; 120: 168-173.
Engel A. Acquired Autoimmune Myasthenia Gravis: Disturbances of Neuromuscular Transmission in Engel GA, Franzini-Armstrong C (eds) Myology, vol 2, McGraw-Hill, New York 1994: 1769- 1797.
Kupersmith M, Moster M, Bhuiyan S, Warren F, Weinberg H. Beneficial effects of Corticosteroids on Ocular Myasthenia Gravis. Arch Neurol 1996; 53: 802-804.
Kuntzer T, Steck AJ, Fiorini E, Mirimanoff RO, Regli F. Syndrme Myasthénique de Lambert-Eaton: Aspects physiopathologiques et modalités thérapeutiques. Rev Neurol (Paris) 1991; 147: 819-824.
O'Neill J, Murray NM, Newsom-Davis J. The lambert-Eaton Myasthenic Syndrome: Review of 50 cases. Brain 1988; 111:
-596.
Abrutyn E. Botulism in lsselbacher, Braunwald, Wilson, Martin, Fauci, Kasper (eds), Harrison's Principies of Internai Medicine, 131• edition, McGraw-Hill 1994: 635-636.
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
